-
Eli Lilly Agrees To Buy Loxo For $8B In Bid To Expand Oncology Franchise
Monday, January 7, 2019 - 10:00am | 478Achieving excellence in oncology franchises is driving large-cap companies to make astute buys of relatively smaller-sized companies with breakthrough pipeline assets in the field. Eli Lilly And Co (NYSE: LLY) has become the latest company to have made a move in this direction. What Happened Less...